EUVIMEDEUVIMED entdecken
Crossref

Luminal B Breast Cancer Coexpressing p62 and ALDH1A3 Is Less Susceptible to Radiotherapy

Ayaka Ozaki, Akari Matsuda, Yuki Maemura, Yuna Tada, Takahiro Kasai, Yuka Nagashima, Chotaro Onaga, Yasushi Hara, Kazuki Kitabatake, Mitsutoshi Tsukimoto, Shoma Tamori, Kazunori Sasaki und 2 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.16786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Ayaka Ozaki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleBiomarkers, TumorBreastAldehyde Dehydrogenase 1 FamilyCell Line, TumorNeoplastic Stem CellsRetinal DehydrogenasePrognosis

Stichwörter der Autor:innen

ALDH1Breast cancercancer stem cellluminal Bp62radiotherapy

Substanzen

Biomarkers, TumorAldehyde Dehydrogenase 1 FamilyRetinal Dehydrogenase

Autor:innen und Institutionen

  • Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
  • Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Research Division of Medical Data Science, Research Institute for Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Laboratory of Cancer Biology, Institute for Diseases of Old Age, Juntendo University School of Medicine, Tokyo, Japan.
  • Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan; akimoto@rs.tus.ac.jp.

Zitieren

APA

Ozaki, A., Matsuda, A., Maemura, Y., Tada, Y., Kasai, T., Nagashima, Y., Onaga, C., Hara, Y., Kitabatake, K., Tsukimoto, M., Tamori, S., Sasaki, K., Ohno, S., & Akimoto, K. (2024). Luminal B Breast Cancer Coexpressing p62 and ALDH1A3 Is Less Susceptible to Radiotherapy. Anticancer Research. https://doi.org/10.21873/anticanres.16786

Vancouver

Ozaki A, Matsuda A, Maemura Y, Tada Y, Kasai T, Nagashima Y, et al. Luminal B Breast Cancer Coexpressing p62 and ALDH1A3 Is Less Susceptible to Radiotherapy. Anticancer Research. 2024. doi:10.21873/anticanres.16786

BibTeX
@article{Ozaki2024,
  author = {Ozaki, Ayaka and Matsuda, Akari and Maemura, Yuki and Tada, Yuna and Kasai, Takahiro and Nagashima, Yuka and Onaga, Chotaro and Hara, Yasushi and Kitabatake, Kazuki and Tsukimoto, Mitsutoshi and Tamori, Shoma and Sasaki, Kazunori and Ohno, Shigeo and Akimoto, Kazunori},
  title = {Luminal B Breast Cancer Coexpressing p62 and ALDH1A3 Is Less Susceptible to Radiotherapy},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.16786}
}
Kostenlos starten →